04/09/2024
7:30 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
8:06 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:30 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2024
3:45 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2024
3:55 PM | Agile Therapeutics (Filer)
| Form 424B5 | |
02/23/2024
3:57 PM | Agile Therapeutics (Filer)
| Form 424B5 | |
02/15/2024
3:45 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
02/13/2024
7:02 PM | Agile Therapeutics (Subject)
Lind Global Fund II LP (Filed by)
| Form SC 13G/A | |
02/06/2024
9:14 AM | Agile Therapeutics (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SC 13G/A | |
02/05/2024
8:21 AM | Agile Therapeutics (Filer)
| Form S-1/A | |
12/20/2023
7:00 AM | Agile Therapeutics (Filer)
| Form S-1/A | |
12/11/2023
4:30 PM | Agile Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/06/2023
7:00 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
7:00 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
7:15 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
3:45 PM | Agile Therapeutics (Issuer)
Coiante Scott M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
3:30 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/28/2023
3:50 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2023
7:30 AM | Agile Therapeutics (Filer)
| Form 8-K/A | |
08/09/2023
7:10 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
3:50 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
3:36 PM | Agile Therapeutics (Issuer)
Gilmore Geoffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
3:37 PM | Agile Therapeutics (Issuer)
Conway Robert G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
3:37 PM | Agile Therapeutics (Issuer)
ALTOMARI ALFRED (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
3:38 PM | Agile Therapeutics (Issuer)
Korner Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
3:38 PM | Agile Therapeutics (Issuer)
Welsh Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
3:46 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
3:35 PM | Agile Therapeutics (Filer)
| Form 8-K/A | |
06/09/2023
4:08 PM | Agile Therapeutics (Issuer)
BARBARI SHARON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:09 PM | Agile Therapeutics (Issuer)
Carson Sandra (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:10 PM | Agile Therapeutics (Issuer)
Hubbard John W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:12 PM | Agile Therapeutics (Issuer)
Fischer Seth H. Z. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:13 PM | Agile Therapeutics (Issuer)
Torrente Josephine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:19 PM | Agile Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/05/2023
7:30 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/25/2023
4:25 PM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/25/2023
11:27 AM | Agile Therapeutics (Filer)
| Form 424B5 | |
05/25/2023
11:29 AM | Agile Therapeutics (Filer)
| Form 424B5 | |
05/25/2023
11:25 AM | Agile Therapeutics (Filer)
| Form 424B5 | |
05/24/2023
3:05 PM | Agile Therapeutics (Filer)
| Form 424B4 | |
05/22/2023
11:15 PM | Agile Therapeutics (Filer)
| Form EFFECT | |
With the “Bitcoin Loophole” you can supercharge the gains by 10x or more (Ad) Thanks to this newly discovered Bitcoin Loophole, you can now trade Bitcoin in any regular brokerage account…
And not only that… you can use it to supercharge the gains of Bitcoin by 10x or more!
You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history.
That means you can skip the hassle of opening a Coinbase account…
Bypass the fees and hard-to-remember passwords… Sign up here for a FREE workshop to discover one trader’s $213,000 real-money trade! |
05/19/2023
11:20 AM | Agile Therapeutics (Filer)
| Form S-1/A | |
05/17/2023
6:30 AM | Agile Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2023
9:38 AM | Agile Therapeutics (Filer)
| Form DEF 14A | |
04/28/2023
7:21 AM | Agile Therapeutics (Filer)
| Form ARS | |
